Bosh sahifaSFOSF • OTCMKTS
add
Shanghai Fosun Pharmaceutical (Group) Ord Shs H
Yopilish kursi
1,70 $
Yillik diapazon
1,50 $ - 2,24 $
Bozor kapitalizatsiyasi
60,97 mlrd HKD
Oʻrtacha hajm
35,00
Narx/foyda
-
Dividend daromadliligi
-
Yangiliklarda
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (CNY) | sen, 2024info | Y/Y qiyosi |
|---|---|---|
Daromad | 10,45 mlrd | 12,30% |
Joriy xarajat | 4,11 mlrd | -4,30% |
Sof foyda | 785,84 mln | 55,43% |
Sof foyda marjasi | 7,52 | 38,49% |
Har bir ulushga tushum | — | — |
EBITDA | 1,60 mlrd | 229,39% |
Amaldagi soliq stavkasi | 15,05% | — |
Balans
Jami aktivlari
Jami passivlari
| (CNY) | sen, 2024info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 15,63 mlrd | -1,12% |
Jami aktivlari | 115,26 mlrd | 4,06% |
Jami passivlari | 56,07 mlrd | 2,35% |
Umumiy kapital | 59,19 mlrd | — |
Tarqatilgan aksiyalar | 2,66 mlrd | — |
Narxi/balansdagi bahosi | 0,10 | — |
Aktivlardan daromad | 2,03% | — |
Kapitaldan daromad | 2,49% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (CNY) | sen, 2024info | Y/Y qiyosi |
|---|---|---|
Sof foyda | 785,84 mln | 55,43% |
Operatsiyalardan naqd pul | 1,08 mlrd | 65,68% |
Sarmoyadan naqd pul | 210,24 mln | 122,80% |
Moliyadan naqd pul | -1,59 mlrd | 11,34% |
Naqd pulning sof oʻzgarishi | -389,75 mln | 80,29% |
Boʻsh pul | -2,97 mlrd | 27,05% |
Haqida
Shanghai Fosun Pharmaceutical Co., Ltd. is a Chinese pharmaceutical company. It is mostly owned by Fosun International.
As of 2018, the A shares of the company is a constituent of SSE 180 Index as well as its sub-index SSE MidCap Index. The company was ranked 1,840th in 2020 edition of the Forbes Global 2000, a list of top listed companies of the world. Wikipedia
Tashkil etilgan
1994
Sayt
Xodimlar soni
39 309
